Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Community-based Sero-epidemiological Study of COVID-19 to Provide Data in Real Time on Age-stratified Infection Attack Rates, Disease Severity and Population Immunity, for Guiding Intervention Policy

NCT05599555 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT05599555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05599555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Community-based Sero-epidemiological Study of COVID-19 to Provide Data in Real Time on Age-stratified Infection Attack Rates, Disease Severity and Population Immunity, for Guiding Intervention Policy
Lead sponsor
The University of Hong Kong
Phase
Observational
Overall status
Completed
Start date
April 28, 2022
Completion date
March 31, 2023
Enrollment
9,600 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19